BSF ENTERPRISE PLC
BSFA | IL
Overview
Corporate Details
- ISIN(s):
- GB00BHNBDQ51
- LEI:
- 2138007PJT69H8FYLC06
- Country:
- United Kingdom
- Address:
- C/O LOCKE LORD (UK) LLP, EC2M 3AB LONDON
- Website:
- https://bsfenterprise.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
BSF Enterprise PLC identifies and invests in innovative and emerging businesses across diverse industries.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-25 08:00 |
Earnings Release
Interim 2025 Results
|
English | 297.7 KB | |
| 2025-05-23 08:00 |
Share Issue/Capital Change
15p Warrants Amended
|
English | 9.3 KB | |
| 2025-03-13 08:00 |
Regulatory News Service
3DBT Lab Grown Leather Commercialization
|
English | 10.7 KB | |
| 2025-03-06 16:51 |
Prospectus
Publication of a Prospectus
|
English | 15.4 KB | |
| 2025-03-06 16:33 |
Prospectus
Publication of Prospectus
|
English | 98.7 KB | |
| 2025-03-06 16:29 |
Prospectus
Prospectus
|
English | 1017.5 KB | |
| 2025-03-05 13:10 |
Declaration of Voting Results & Voting Rights Announcements
Result of Annual General Meeting
|
English | 27.3 KB | |
| 2025-02-11 09:21 |
Regulatory News Service
Expected admission of shares - Replacement
|
English | 8.6 KB | |
| 2025-02-11 08:00 |
Capital/Financing Update
AIM Admission - Update
|
English | 8.3 KB | |
| 2025-02-10 08:00 |
AGM Report
AGM Statement
|
English | 9.7 KB | |
| 2025-02-07 18:23 |
Proxy Solicitation & Information Statements
Proxy Form
|
English | 125.0 KB | |
| 2025-02-07 18:21 |
AGM Report
Notice of AGM
|
English | 198.2 KB | |
| 2025-01-31 15:44 |
Annual Report
Annual Report and Financial Statements for the year ended 30 September 2024
|
English | 2.3 MB | |
| 2025-01-31 13:41 |
Earnings Release
Annual Financial Report
|
English | 767.8 KB | |
| 2025-01-31 13:31 |
Earnings Release
Annual Financial Report
|
English | 17.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |